Pyrazoline-Based Molecules In Antimicrobial Research: A Systematic Review
Abstract
Pyrazoline derivatives have become important compounds in medicinal chemistry because of their extensive array of biological activities, especially their antibacterial properties. The escalating problem of antimicrobial resistance (AMR) and the rising incidence of fungal infections underscore the urgent demand for new therapeutic agents. Pyrazoline derivatives, characterized by their unique five-membered heterocyclic framework, exhibit strong antibacterial and antifungal effects through mechanisms that involve interactions with microbial enzymes, DNA, and cellular membranes. Developments in synthetic methods, including environmentally friendly techniques and computational drug design, have facilitated the synthesis of derivatives with enhanced efficacy and reduced resistance. This review encapsulates recent progress in the synthesis, structural diversity, and biological efficacy of pyrazoline derivatives, emphasizing their significance in addressing global infectious disease challenges. It also reviews commercially available antimicrobial agents and the specific modifications that enhance pharmacokinetic and pharmacodynamic properties. The potential future applications of pyrazoline derivatives in combating AMR and invasive fungal infections are thoroughly examined, offering a comprehensive reference for advancing research and therapeutic innovations in this field.
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: A prospective multicentric study
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
- New drug approvals for 2022: Synthesis and clinical applications
- Coated Microneedle System for Delivery of Clotrimazole in Deep-Skin Mycoses
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.